PE Week Wire — 8/24/06

TSG Consumer Partners has sold its 30% stake in enhanced bottled water company Glaceau (a.k.a. Energy Brands Inc.) to The Tata Group. The deal is valued at $677 million, including both the TSG stake and additional growth capital. Glaceau is a New York-based company whose brands include of Vitaminwater, Fruitwater and Smartwater. www.glaceau.com

ChemoCentryx Inc., a Mountain View, Calif.-based developer of orally-administered therapeutics that target chemokine and chemoattractant receptor systems, has raised $17.7 million in Series C funding. Backers include Jennison Associates, HBM BioVentures, Orbimed Advisors, Techne Corporation, Alta Partners and GIMV. ChemoCentryx also announced a strategic alliance with GlaxoSmithKline that includes an upfront payment of $63.5 million in cash and equity. The GSK deal also includes research funding and milestone payments that potentially could be worth up to $1.5 billion. www.chemocentryx.com

Vestar Capital Partners of New York is opening a Tokyo-based affiliate to focus on middle market private equity opportunities in Japan. The effort will be led by Daisuke Saji, former managing director of Daiwa SMBC and global head of its M&A department. He will be joined by fellow Daiwa vets Taro Sumitani and Shinji Sunouchi, while longtime Vestar managing director John Woodard will help integrate Vestar Japan with the larger firm. www.vestarcapital.com

Kemia Inc., a San Diego-based drug company focused on high-value disease targets not yet addressed by non-injectable drugs, has raised $31 million in Series C funding. Aberdare Ventures led the deal, and was joined by MedImmune Ventures, Red Abbey Venture Partners and return backers Alta Partners, Forward Ventures, Hamilton Bioventures, JPMorgan Partners, Novartis Bioventures, Novo AS and Texas Pacific Group in the financing. The company has now raised around $85 million in total VC funding since its 2002 inception. www.kemia.com

Octagon Research Solutions Inc., a Wayne, Pa.-based provider of R&D process management solutions for the pharma industry, has raised $10 million in third round funding. Participants include Edison Venture Fund, Phoenix Life Insurance, Ticonderoga Capital and Zurich Financial. www.octagonresearch.com

Kane Reid Securities Group (a.k.a. TradeKing), a Boca Raton, Fla.-based provider of online brokerage services, has raised $6 million in Series B funding, according to a regulatory filing. Battery Ventures led the deal, while existing shareholders include Milestone Merchant Partners and OCA Venture Partners. www.tradeking.com

IPLocks Inc., a San Jose, Calif.